General population surveys of drug use

Overview of the data  |  Tables  |  Graphics  |  Supplementary downloadable tables  |  Methods and definitions

Overview of the data

The links above give access to the tables and graphics in the bulletin, the supplementary downloadable tables and the associated graphics in the section dealing with general population surveys, as well as to a description of the methods and definitions used in compiling this data. A brief overview is provided below. See also the side navigation bar for links to all chapters.

Drug use in the general population is assessed through surveys, which provide estimates of the proportion of the population that has used different drugs over standard periods of time; lifetime use (or ‘ever-use’), last twelve months use (‘recent use’) or last 30 days use (‘current use’). The general population survey data give information by Member States, by geographic region within states and by year of survey, according to availability. The information covers self-reported use of cannabis, cocaine, amphetamines, ecstasy, hallucinogens and specifically LSD. A summary of the survey structure is given (Table GPS-14) and also a bibliographic reference to the published source (Table GPS-0).

Tables GPS-1 to GPS-6 give prevalence estimates of individual drug types for reported lifetime (ever-) use, use in the past year and use in the past month, each for the general population aged 15 to 64 and for the younger part of the population, aged 15 to 34. In Table GPS-1 part (ii) some survey structure details are given that are the same for each of tables GPS-1 to GPS-6.

Similarly, tables GPS-8 to GPS-13 give parallel information on prevalence for the last survey available for each Member State, and Table GPS-8 part (ii) gives some survey structure details that are the same for each of tables GPS-8 to GPS-13.

Summary points